Skip to main content
Clinical Trials/CTRI/2026/01/101133
CTRI/2026/01/101133
Not yet recruiting
Not Applicable

Comparison of the efficacy between Ultrasound guided Supraclavicular brachial plexus block and Infraclavicular brachial plexus block using 0.5 percent Ropivacaine in forearm surgeries - A prospective randomised double blind study

SRM Institutes for Medical Sciences1 site in 1 country58 target enrollmentStarted: January 20, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
SRM Institutes for Medical Sciences
Enrollment
58
Locations
1
Primary Endpoint
Onset time and duration of sensory and motor block assessed using pinprick test and Modified Bromage scale in the radial, median, and ulnar nerve distributions

Overview

Brief Summary

This is a prospective, randomised, double-blinded comparative clinical trial evaluating the efficacy of ultrasound-guided supraclavicular brachial plexus block versus ultrasound-guided infraclavicular brachial plexus block in adult patients undergoing forearm surgeries. Fifty-eight patients aged 20 to 60 years with ASA physical status I or II will be enrolled and allocated to one of the two groups using computer-generated randomisation. Both groups will receive 20 mL of 0.5% ropivacaine as a single-shot injection under ultrasound guidance. The primary outcome measures are onset time and duration of sensory and motor block. Secondary outcomes include time to first request for rescue analgesia, total rescue analgesic requirement in the first 24 hours, postoperative pain scores, and block-related complications. Assessments will be conducted intraoperatively and up to 24 hours post-procedure.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • ASA physical status grade I or II,Age between 20 and 60 years,Both male and female patients,Body mass index less than 30 kg/m2,Patients admitted for forearm surgeries,Patients willing to participate and provide written informed consent.

Exclusion Criteria

  • ASA physical status grade III, IV, or V,Age less than 20 years or greater than 60 years,Pregnant or lactating women,Body mass index greater than or equal to 30 kg/m2,Participation in any other clinical study,Known allergy to local anaesthetics or any drugs used in this study,Patients not willing to participate,Presence of bleeding disorder,Presence of infection at the site of block.

Outcomes

Primary Outcomes

Onset time and duration of sensory and motor block assessed using pinprick test and Modified Bromage scale in the radial, median, and ulnar nerve distributions

Time Frame: Onset assessed every minute from completion of local anaesthetic injection until full block achieved intraoperatively; duration assessed at 30 minute intervals post-procedure until complete recovery, up to 24 hours after block

Secondary Outcomes

  • Time to first request for rescue analgesia, requirement for rescue analgesia in the first 24 hours, Visual Analogue Scale pain scores, and incidence of block-related complications including vascular puncture, pneumothorax, or nerve injury(Pain scores recorded at 2, 4, 6, 12, and 24 hours postoperatively; rescue analgesia requirement monitored throughout the first 24 hours; complications noted intraoperatively and during the postoperative 24-hour observation period)

Investigators

Sponsor
SRM Institutes for Medical Sciences
Sponsor Class
Private hospital/clinic
Responsible Party
Principal Investigator
Principal Investigator

DrAswinK

SRM Institutes for Medical Sciences (SIMS)

Study Sites (1)

Loading locations...

Similar Trials